Literature DB >> 9038223

Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation.

M Molino1, D F Bainton, J A Hoxie, S R Coughlin, L F Brass.   

Abstract

Platelet responses to thrombin are at least partly mediated by a G-protein-coupled receptor whose NH2 terminus is a substrate for thrombin. In the present studies we have examined the location of thrombin receptors in resting platelets and followed their redistribution during platelet activation. The results reveal several new aspects of thrombin receptor biology. 1) On resting platelets, approximately two-thirds of the receptors were located in the plasma membrane. The remainder were present in the membranes of the surface connecting system. 2) When platelets were activated by ADP or a thromboxane analog, thrombin receptors that were initially in the surface connecting system were exposed on the platelet surface, increasing the number of detectable receptors by 40% and presumably making them available for subsequent activation by thrombin. 3) Platelet activation by thrombin rapidly abolished the binding of the antibodies whose epitopes are sensitive to receptor cleavage and left the platelets in a state refractory to both thrombin and the agonist peptide, SFLLRN. This was accompanied by a 60% decrease in the binding of receptor antibodies directed COOH-terminal to the cleavage site irrespective of whether the receptors were activated proteolytically by thrombin or nonproteolytically by SFLLRN. 4) The loss of antibody binding sites caused by thrombin was due in part to receptor internalization and in part to the shedding of thrombin receptors into membrane microparticles, especially under conditions in which aggregation was allowed to occur. However, at least 40% of the cleaved receptors remained on the platelet surface. 5) Lacking the ability to synthesize new receptors and lacking an intracellular reserve of preformed receptors comparable to that found in endothelial cells, platelets were unable to repopulate their surface with intact receptors following exposure to thrombin. This difference underlies the ability of endothelial cells to recover responsiveness to thrombin rapidly while platelets do not, despite the presence on both of the same receptor for thrombin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038223     DOI: 10.1074/jbc.272.9.6011

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.

Authors:  M L Kahn; M Nakanishi-Matsui; M J Shapiro; H Ishihara; S R Coughlin
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 3.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

4.  Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets.

Authors:  J F Hussain; M P Mahaut-Smith
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

Review 5.  Novel anti-platelet agents: focus on thrombin receptor antagonists.

Authors:  Flavio de Souza Brito; Pierluigi Tricoci
Journal:  J Cardiovasc Transl Res       Date:  2013-02-22       Impact factor: 4.132

6.  Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.

Authors:  T M Getz; C A Dangelmaier; J Jin; J L Daniel; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

7.  Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization.

Authors:  May M Paing; Christopher A Johnston; David P Siderovski; Joann Trejo
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets.

Authors:  Jianguo Jin; Yingying Mao; Dafydd Thomas; Soochong Kim; James L Daniel; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2008-11-25       Impact factor: 5.858

9.  A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation.

Authors:  F A Ofosu; J Freedman; L Dewar; Y Song; J W Fenton
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in mice.

Authors:  Yingying Mao; Ming Zhang; Ronald F Tuma; Satya P Kunapuli
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.